Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optopics was a pharmaceutical company specializing in the development and manufacture of ophthalmic products, including prescription and over-the-counter eye care solutions. Based in Fairton, New Jersey, the company produced a wide range of diagnostic stains, ointments, and surgical aids used by eye care professionals. It was acquired by Akorn in 1998 to expand Akorn's ophthalmic product portfolio and manufacturing capacity. Following the acquisition, Optopics operated as a subsidiary and manufacturing facility until the eventual dissolution of Akorn's operations in 2023. The company was known for its focus on niche ophthalmic generics and diagnostic tools. Its product line included well-known diagnostic agents like Rose Bengal and Fluorescein Sodium.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optopics.